Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of new formulation lopinavir/ritonavir in genital tract and plasma of HIV-infected pregnant women
2006-006297-23Phase 4Terminated
- Sponsor
- Guy's and St Thomas' NHS Foundation Trust
- Start
- Jan 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV), sponsored by Guy's and St Thomas' NHS Foundation Trust. Primary endpoint: Total lopinavir levels in plasma and female genital tract. Started Jan 2009; status: terminated.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2006-006297-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006297-23.